Literature DB >> 15834646

Lambert-Eaton Myasthenic syndrome associated with sarcoidosis.

F Purroy García, M Comabella, N Raguer, J Majó, X Montalban.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15834646     DOI: 10.1007/s00415-005-0807-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  5 in total

Review 1.  Sarcoidosis.

Authors:  L S Newman; C S Rose; L A Maier
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

2.  Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients.

Authors:  Y K Nakao; M Motomura; T Fukudome; T Fukuda; H Shiraishi; T Yoshimura; M Tsujihata; K Eguchi
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

Review 3.  Sarcoidosis and other autoimmune disorders.

Authors:  Om P Sharma
Journal:  Curr Opin Pulm Med       Date:  2002-09       Impact factor: 3.155

4.  Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases.

Authors:  Paul W Wirtz; Thierry M Smallegange; Axel R Wintzen; Jan J Verschuuren
Journal:  Clin Neurol Neurosurg       Date:  2002-09       Impact factor: 1.876

5.  The Lambert-Eaton myasthenic syndrome. A review of 50 cases.

Authors:  J H O'Neill; N M Murray; J Newsom-Davis
Journal:  Brain       Date:  1988-06       Impact factor: 13.501

  5 in total
  2 in total

1.  Clinical Features of Neuromuscular Disorders in Patients with N-Type Voltage-Gated Calcium Channel Antibodies.

Authors:  Andreas Totzeck; Petra Mummel; Oliver Kastrup; Tim Hagenacker
Journal:  Eur J Transl Myol       Date:  2016-09-15

2.  Autonomic dysfunction detected by skin sympathetic response in Lambert-Eaton myasthenic syndrome: a case report.

Authors:  Jinghong Zhang; Xusheng Huang; Qiang Shi
Journal:  BMC Neurol       Date:  2022-03-19       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.